Skip to main content

Temozolomide News

Updated Recommendations Issued for Management of Grade 4 Diffuse Glioma

TUESDAY, July 8, 2025 – In a clinical practice guideline issued by the American Society for Radiation Oncology and published online June 25 in Practical Radiation Oncology, updated recommendations...

FDA Approves New and Updated Indications for Temozolomide Under Project Renewal

On September 14, 2023, the Food and Drug Administration (FDA) approved updated labeling for temozolomide (Temodar, Merck) under Project Renewal, an Oncology Center of Excellence (OCE) initiative...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Melanoma

Temozolomide patient information at Drugs.com